Lamassu Pharma, LLC — Form D

Lamassu Pharma, LLC of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-04. The offering totals $2.9M, of which $2.7M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2020-05-04
• Form: D
• Accession: 0001810800-20-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $2.9M
• Amount sold: $2.7M
• Remaining: $235K
• Minimum investment: $50K
• Investors: 19
• Date of first sale: 2020-04-21
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-366203

Issuer

• Name: Lamassu Pharma, LLC
• CIK: 0001810800
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 3520 KANGAROO DRIVE, DURHAM, NC, 27715
• Phone: 919-667-8571

Officers, directors & promoters (4)

More

• CIK 1810800 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search